Denosumab for treatment of breast cancer bone metastases and beyond
Julie R. Nangia(Unknown), Meghana V. Trivedi(University of Houston), Christine M. Nguyen(Light Prescriptions Innovators (United States)), D. Joseph(University of California San Diego), Margaret Mendes(VA San Diego Healthcare System)
Cited by 5
Related Papers
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications
|Breast Care|2013|200
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
|Proceedings of the National Academy of Sciences|2016|185
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
|Cancer Discovery|2022|139